series-a
Stage
1
Investors
About
Scala Biodesign develops a cloud-based computational platform that uses physics-based modeling, evolutionary data, and AI to design optimized proteins, enzymes, antibodies, and therapeutic proteins for pharmaceutical, chemical, and biotech industries.
Explore Scala Biodesign's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.